USPTO serial 87350060
DXTERITY
Reviewed by CopyMark Law Group
Reg. 5630340Status 710
- Filing date
- Status date
- Registration date
- Dec 18, 2018
- Examiner
- SHINER, MARK W
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with DXTERITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DxTerity Diagnostics Incorporated
Rancho Dominguez, CA
DxTerity Diagnostics Incorporated
Rancho Dominguez, CA
DxTerity Diagnostics Incorporated
Rancho Dominguez, CA
DXTERITY DIAGNOSTICS INCORPORATED
RANCHO DOMINGUEZ, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay J. Hulley
Lindsay J. Hulley Rutan & Tucker, LLP18575 Jamboree Road9th FloorIrvine, CO 92612Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations for scientific use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; all of the foregoing for use in connection with genomic molecular diagnostic testing | SECTION 8 - CANCELLED | — |
| 005 | Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, autoimmune disease; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; all of the foregoing for use in connection with genomic molecular diagnostic testing | SECTION 8 - CANCELLED | — |
| 010 | Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood testing apparatus, namely, blood collecting tubes; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical specimen collection devices in the nature of fingerstick device for the collection of blood; Medical specimen collection devices in the nature of evacuated tube for the collection of blood; all of the foregoing for use in connection with genomic molecular diagnostic testing | SECTION 8 - CANCELLED | — |
| 044 | Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of biodosimetry; Medical testing for diagnostic or treatment purposes in the field of cancer; Medical testing for diagnostic or treatment purposes in the field of autoimmune disease; all of the foregoing for use in connection with genomic molecular diagnostic testing | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DxTerity Diagnostics Incorporated
- Other trademarks owned by DxTerity Diagnostics Incorporated
- Other trademarks owned by DxTerity Diagnostics Incorporated
- Other trademarks owned by DXTERITY DIAGNOSTICS INCORPORATED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named DXTERITY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 4, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 18, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 27, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 13, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Oct 12, 2021 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Oct 12, 2021 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Oct 12, 2021 | PLGL | ASSIGNED TO PARALEGAL | — |
| May 25, 2021 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 18, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 2, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 2, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 12, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 30, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 24, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 24, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 7, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 7, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 7, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 20, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 20, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 18, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 18, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 18, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 2, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 2, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 20, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2017 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 22, 2017 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 22, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 22, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2017 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Mar 6, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 1, 2017 | NWAP | NEW APPLICATION ENTERED | — |